Получена: 22.02.2023 / Принята: 06.06.2023 / Опубликована online: 30.06.2023
УДК 615.065+614.35:378.147
DOI 10.53511/PHARMKAZ.2023.60.36.032
Е.В. Матвеева, Е.В.Ткаченко, А.И. Дьяченко, А.В. Зайченко, К.С. Жакипбеков, К.Е. Сагиндыкова
Национальный медицинский университет имени А.А. Богомольца, Киев, Украина
Казахский Национальный медицинский университет им. С.Д. Асфендиярова, Алматы, Казахстан
ПОДХОДЫ К ПРЕПОДАВАНИЮ ФАРМАКОНАДЗОРА
В ВЫСШИХ УЧЕБНЫХ ЗАВЕДЕНИЯХ
Резюме: Нежелательные реакции (НР) лекарственных средств (ЛС) представляют собой серьезную проблему фармакотерапии и являются дополнительным физическим, моральным и материальным бременем, как для пациентов, так и для системы здравоохранения (СЗ).
Несмотря на то, что фармаконадзор (ФН) является одной из основных составляющих обращения
ЛС в странах, где этот процесс урегулирован на законодательном уровне, его осуществление
имеет ряд пробелов. По мнению авторов статьи, к ним прежде всего относится проблема подготовки медицинских работников (специалистов, получивших высшее, среднее специальное медицинское или фармацевтическое образование) по вопросам ФН на до- и последипломном этапах обучения.
Хотя ФН имеет важное значение при проведении фармакотерапии, медицинские работники имеют
о нем ограниченные знания. Опыт авторов этой публикации свидетельствует, что уровень осведомленности медицинских работников в основном сводится к сообщениям о НР ЛС. Небольшое
количество медицинских работников имеет целостное представление о ФН, его роли и значении
для отдельно взятого пациента, общественного здоровья и/или для системы здравоохранения.
Современные подходы к оказанию медицинской помощи, повышение значения рационального назначения ЛС и предотвращения НР ЛС являются факторами, определяющими необходимость приобретения адекватных знаний и компетенций в области ФН для специалистов СЗ. В связи с вышеизложенным, мы поставили задачу определить круг образовательных мероприятий , которые были
бы эффективны в продвижении ФН.
Ключевые слова: Фармаконадзор, нежелательные реакции лекарственных средств, медицинские
работники, студенты, преддипломное и постдипломное образование
СПИСОК ЛИТЕРАТУРЫ
1 Brinkman DJTJ, Mokkink LB, Christiaens T, Likic R, Maciulaitis R, Costa J, Sanz EJ, Maxwell SR, Richir MC, van Agtmael MA, Education Working Group of
the European Association for Clinical Pharmacology and Therapeutics (2017) Key learning outcomes for clinical pharmacology and therapeutics education in
Europe: a modified Delphi study. Clin Pharmacol Ther
2 Maxwell SR, Cascorbi I, Orme M, Webb DJ, Joint BPS/EACPT Working Group on Safe Presribing (2007) Educating European (junior) doctors for safe
prescribing. Basic Clin Pharmacol Toxicol 101:395–400
3 de Vries TPGM, Henning RH, Hogerzeil HV, Fresle DA (1994) Guide to good prescribing—a practical manual. WHO, Geneva
4 Jenny Hartman LH, van Puijenbroek E (2017) A global view of undergraduate education in pharmacovigilance. Eur J Clin Pharmacol 73:891–899
5 Abdullahi Rabiu Abubakar MH (2016) Pharmacovigilance practice: the current challenges and the gaps in the medical students’ curriculum. J App Pharm
Sci 6(05):210–2015
6 Gavaza P, Bui B (2012) Pharmacy students’ attitudes toward reporting serious adverse drug events. Am J Pharm Educ 76(10):194
7 De Angelis A, Colaceci S, Giusti A, Vellone E, Alvaro R (2015) Factors that condition the spontaneous reporting of adverse drug reactions among nurses: an
integrative review. J Nurs Manag 23(4):1–18.
8 Pagotto C, Varallo F, Mastroianni P (2013) Impact of educational interventions on adverse drug events reporting. Int J Technol Assess Health Care 29(4):410–
417
9 Rutter P, Brown D, Howard J, Randall C (2014) Pharmacists in pharmacovigilance: can increased diagnostic opportunity in community settings translate to
better vigilance Drug Saf 37(7):465–469
10 Gonzalez-Gonzalez C, Lopez-Gonzalez E, Herdeiro MT, Figueiras A (2013) Strategies to improve adverse drug reaction reporting: a critical and systematic
review. Drug Saf 36(5):317–328
11 Lopez-Gonzalez E, Herdeiro MT, Figueiras A (2009) Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Saf 32(1):19–31
12 WH I (1996) Attitudes to adverse drug reaction reporting. Br J Clin Pharmacol 41(5):434–435
13 Alessia De Angelis SC, Giusti A, Vellone E, Alvaro R (2015) Factors that condition the spontaneous reporting of adverse drug reactions among nurses: an
integrative review. J Nurs Manag 24(2)
14 Herdeiro MT, Ribeiro-Vaz I, Ferreira M, Polnia J, Falco A, Figueiras A (2012) Workshop-and telephone-based interventions to improve adverse drug reaction
reporting: a cluster-randomized trial in Portugal. Drug Saf 35(8):655–665
15 Johansson-Pajala RM, Martin L, Fastbom J, Blomgren KJ (2015) Nurses’ self-reported medication competence in relation to their pharmacovigilant activities
in clinical practice. J Eval Clin Pract 21(1):145–152
16 Ribeiro-Vaz I, Santos CC, Cruz-Correia R (2016) Promoting adverse drug reaction reporting: comparison of different approaches. Rev Saude Publica 50:14
17 Ribeiro-Vaz IH, T M, Polonia J, Figueiras A (2011) Strategies to increase the sensitivity of pharmacovigilance in Portugal. Rev Saude Publica 45(1):129–135
18 Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA
279(15):1200–1205
19 Krähenbühl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krähenbühl S (2007) Drug-related problems in hospitals: a review of the recent
literature. Drug Saf 30(5):379–407
20 Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM (2004) Adverse drug reactions as cause of
admission to hospital: prospective analysis of 18 820 patients. BMJ 329(7456):15–19
21 Gyllensten HRC, Jonsson AK, Petzold M, Carlsten A, Andersson Sundell K (2013) Cost of illness of patient-reported adverse drug events: a populationbased cross-sectional survey. BMJ Open 3(6):e002574
22 Sultana J, Cutroneo P, Trifiro G (2013) Clinical and economic burden of adverse drug reactions. J Pharmacol Pharmacother 4(Suppl 1):S73–S77
23 van Grootheest K (2003) The dawn of pharmacovigilance: an historical perspective. Int J Pharmaceut Med 17:195. https://doi.org/10.2165/00124363-
200317050-00006
24 Hall M, McCormack P, Arthurs N, Feely J (1995) The spontaneous reporting of adverse drug reactions by nurses. Br J Clin Pharmacol 40(2):173–175
25 Bigi CBG (2017) The key role of clinical and community health nurses in pharmacovigilance. Eur J Clin Pharmacol 73:1379–1387
26 Carnelio S, Khan SA, Rodrigues G (2011) Pharmacovigilance in clinical dentistry: overlooked or axiomatic? Gen Dent 59(1):24–28 quiz 9–30, 80
27 Schutte T, van Eekeren R, Richir M, van Staveren J, van Puijenbroek E, Tichelaar J, van Agtmael M (2017) The adverse drug reaction reporting assignment
for specialist oncology nurses: a preliminary evaluation of quality, relevance and educational value in a prospective cohort study. Naunyn Schmiedeberg’s
Arch Pharmacol
28 Atkin PASG (1995) Medication-related adverse reactions and the elderly: a literature review. Adverse Drug React Toxicol Rev 14:175–191
29 Hazell L, Shakir SA (2006) Under-reporting of adverse drug reactions: a systematic review. Drug Saf 29(5):385–396
30 Backstrom M, Mjorndal T, Dahlqvist R (2004) Under-reporting of serious adverse drug reactions in Sweden. Pharmacoepidemiol Drug Saf 13(7):483–487
31 Freeth D, Hammick M, Koppel I, Reeves S, Barr H (2002) A critical review of evaluations of interprofessional education. Higher Education Academy Learning
and Teaching Support Network. Available at https://www.caipe.org/news/freeth-d-hammick-m-koppel-i-reeves-s-barr-h-al-2002-a-critical-review-of-evaluationsof-interprofessional-education-hea-health-sciences-and-practice-occasional-paper-2
32 Wohlin C. Guidelines for snowballing in systematic literature studies and a replication in software engineering. [Available from: https://dl.acm.org/citation.
cfm?id=2601268
33 Hammick MDT, Steinert Y (2010) Conducting a best evidence systematic review. Part 1: from idea to data coding. BEME Guide No 13. Med Teach 32:3–15
34 Steinert YMK, Centeno A, Dolmans D, Spencer J, Gelula M et al (2006) A systematic review of faculty development initiatives designed to improve teaching
effectiveness in medical education: BEME Guide No. 8. Med Teach 28:497–526
35 Reed DACD, Beckman TJ, Levine RB, Kern DE, Wright SM (2007) Association between funding and quality of published medical education research.
JAMA 298:1002–1009
36 Bogetz JFRC, Bereknyei S, Mendoza FS, Sanders LM, Braddock CH 3rd (2015) Training health care professionals for 21st-century practice: a systematic
review of educational interventions on chronic care. Acad Med 90(11):1561–1572
37 Ahmad A, Khan MU, Moorthy J, Kumar BD, Kumar GS, Patel I (2016) Comparison of knowledge, attitudes and perceived barriers towards adverse drug
reactions reporting between Bachelor of Pharmacy and Doctor of Pharmacy students in Southern India. J Pharm Health Serv Res 7(1):63–69
38 Rajiah K, Maharajan MK, Nair S (2015) Pharmacy students’ knowledge and perceptions about adverse drug reactions reporting and pharmacovigilance.
Saudi Pharm J. https://doi.org/10.1016/j.jsps.2015.03.021
39 Saurabh MK, Karnani RK (2016) An evaluation of knowledge, attitude and perception about adverse drug reactions and pharmacovigilance among intern
doctors at a teaching hospital of Rajasthan. National Journal of Physiology, Pharmacy and Pharmacology 6(2):111–115
40 Schutte T, Tichelaar J, Reumerman MO, van Eekeren R, Rissmann R, Kramers C, Richir MC, van Puijenbroek EP, van Agtmael MA (2017) Pharmacovigilance
skills, knowledge and attitudes in our future doctors—a nationwide study in the Netherlands. Basic Clin Pharmacol Toxicol 120(5):475–481. https://doi.
org/10.1111/bcpt.12712
41 Abubakar A, Chedi B, Mohammed K, Haque M (2015) Perception of Nigerian medical students on adverse drug reaction reporting. J Adv Pharm Technol
Res 6(4):154–158
42 Abubakar AR, Simbak NB, Haque M (2015) Pharmacovigilance study: awareness among medical students of a new medical school of Malaysia. International
Journal of Pharmaceutical Research 7(1):83–88
43 Farha RA, Alsous M, Elayeh E, Hattab D (2015) A cross-sectional study on knowledge and perceptions of pharmacovigilance among pharmacy students
of selected tertiary institutions in Jordan. Trop J Pharm Res 14(10):1899–1905. https://doi.org/10.4314/tjpr.v14i10.23
44 Ismail SB, Rahman NIA, Anantrao NH, Dali WPEW, Umar BU, Haque M (2015) Awareness of pharmacovigilance among future house officers; a study
among first batch of final year medical students of UniSZA, Malaysia. International Journal of Pharmaceutical Research. 7(2):96–101
45 Meher BR, Joshua N, Asha B, Mukherji D (2015) A questionnaire based study to assess knowledge, attitude and practice of pharmacovigilance among
undergraduate medical students in a Tertiary Care Teaching Hospital of South India. Perspect Clin Res 6(4):217–221
46 Shalini S, Mohan S (2015) Knowledge and attitude towards pharmacovigilance and adverse drug reaction reporting among dental students in a Private
University, Malaysia. J Young Pharm 7(2):118–125. https://doi.org/10.5530/jyp.2015.2.10
47 Umair Khan M, Ahmad A, Ejaz A, et al. (2015) Comparison of the knowledge, attitudes, and perception of barriers regarding adverse drug reaction reporting
between pharmacy and medical students in Pakistan. J of Educ Eval Health Prof 12:28. https://doi.org/10.3352/jeehp.2015.12.28
48 Iffat W, Shakeel S, Naseem S, Imam S, Khan M (2014) Attitudinal survey to assess medical and dental students’ belief of ADR reporting in Pakistan. Int J
Pharm Pharm Sci 6(5):279–283
49 Segun S, Fakeye T (2013) The concept of adverse drug reaction reporting: awareness among pharmacy students in a Nigerian university. Internet J Med
Update 8:24–30
50 Hema NG, Bhuvana KB (2012) Sangeetha. Pharmacovigilance: the extent of awareness among the final year students, interns and postgraduates in a
government teaching hospital. J Clin Diagn Res 6(7 SUPPL):1248–1253
51 Sharma S, Sharma J, Aggarwal T (2012) A survey on knowledge and perception of pharmacy students towards adverse drug reaction (ADR) reporting.
Asian Journal of Pharmaceutical and Clinical Research 5(SUPPL. 3):129–131
52 Vora MB, Paliwal NP, Doshi VG, Barvaliya MJ, Tripathi CB (2012) Knowledge of adverse drug reactions and pharmacovigilance activity among the
undergraduate medical students of GUJARAT. Int J Pharm Sci Res 3(5):1511–1515
53 Elkalmi RM, Hassali MA, Ibrahim MI, Widodo RT, Efan QM, Hadi MA (2011) Pharmacy students’ knowledge and perceptions about pharmacovigilance in
Malaysian public universities. Am J Pharm Educ 75(5):96
54 Sears EL, Generali JA (2005) Adverse drug reaction and medication error reporting by pharmacy students. Ann Pharmacother 39(3):452–459. https://doi.
org/10.1345/aph.1E369
55 Rehan HS, Vasudev K, Tripathi CD (2002) Adverse drug reaction monitoring: knowledge, attitude and practices of medical students and prescribers. Natl
Med J India 15:24–26
56 Sivadasan SSM (2015) A study on the awareness and attitude towards pharmacovigilance and adverse drug reaction reporting among nursing students in
a private university, Malaysia. Int J Curr Pharm Res 7:84–89
57 Sivadasan SYN, Chyi NW et al (2014) Knowledge and perception towards pharmacovigilance and adverse drug reaction reporting among medicine and
pharmacy students. WJPPS
58 Etminani-Isfahani MAM, Mousavi S, Rakhshan A, Assarian M, Kuti L, Eslami K (2013) Adverse drug reaction: knowledge, attitude and practice of pharmacy
students. Journal of Pharmaceutical Care
59 M. Limuaco O (2014) The extent of pharmacovigilance awareness among pharmacy senior students of Centro Escolar University, Manila, Philippines.
Journal of Pharmacovigilance;02(01)
60 Rosebraugh CJ, Tsong Y, Zhou F, Chen M, Mackey AC, Flowers C et al (2003) Improving the quality of adverse drug reaction reporting by 4th-year medical
students. Pharmacoepidemiol Drug Saf 12(2):97–101. https://doi.org/10.1002/pds.797
61 Abubakar AR, Ismail S, Rahman NI, Haque M (2015) Comparative study on drug safety surveillance between medical students of Malaysia and Nigeria.
Ther Clin Risk Manag 11:1015–1025
62 JW RMT (1977) Pathogenesis of adverse drug reactions. In: DM D (ed) Textbook of adverse drug reactions. 10. Oxford University Press, Oxford
63 Sharma A, Amarnath S, Jaikumar S, Basalingappa S, Ramaswamy S, Thulasimani M (2014) Assessment of knowledge about pharmacovigilance among
medical students in Puducherry. Research Journal of Pharmacy and Technology 7(4):447–449
64 Schutte T, Tichelaar J, Reumerman MO, Van Eekeren R, Rolfes L, Richir MC et al (2015) Learning by doing in the student-run pharmacovigilance program.
Clin Ther 37((8):e79
65 Mohan L, Kumar A, Mishara MR, Kishore A, Nayak V (2012) Usefulness of training of pharmacovigilance for medical students—a perspective study. Int J
Pharm Sci Rev Res 16(1):56–59
66 Lokesh Reddy VJP, Rathinavelu SK, Padmanabha M, Reddy Y (2014) Assessment of knowledge, attitude and perception of pharmacovigilance and adverse
drug reaction (ADR) reporting among the pharmacy students in South India. Journal of Pharmacy and Biological Sciences
67 Schutte T, Tichelaar J, Reumerman MO, Van Eekeren R, Rolfes L, Richir MC et al (2017) Feasibility and educational value of a student-run pharmacovigilance
programme: a prospective cohort study. Drug Saf 40(5):409–418
68 Arici AM, Gelal A, Demiral Y, Tuncok Y (2011) Short-term impacts of pharmacovigilance education on the pharmacovigilance knowledge level of fifth-year
medical students. Drug Saf 34(10):1005
69 Amarnath S, Sharma A, Jaikumar S, Basalingappa S, Ramaswamy S, Thulasimani M (2014) Impact of an educational intervention on the awareness of
pharmacovigilance among pharmacy and nursing students in Puducherry. Res J Pharm Biol Chem Sci 5(2):1130–1136
70 Armando P, Uema S, Solá N (2003) Pharmacotherapeutic monitoring in supervised student practice sessions: the application of Dáder methodology in the
identification of ADR. Ars Pharmaceutica 44(2):185–192
71 Chandy SJ (2016) The need for a comprehensive medication safety module in medical education. Indian J Pharmacol. 48(Suppl 1):S57–S60
72 Christensen ST, Sondergaard B, Honore PH, Bjerrum OJ (2011) Pharmacy student driven detection of adverse drug reactions in the community pharmacy
setting. Pharmacoepidemiol Drug Saf 20(4):399–404
73 Durrieu G, Hurault C, Bongard V, Damase-Michel C, Montastruc JL (2007) Perception of risk of adverse drug reactions by medical students: influence of a
1 year pharmacological course. Br J Clin Pharmacol 64(2):233–236
74 Durrieu G, Hurault C, Damase-Michel C, Montastruc JL (2010) Perception of risk of adverse drug reactions: a 3-year follow-up of a cohort of medical
students. Fundam Clin Pharmacol 24(4):423–427
75 Naritoku DK, Faingold CL (2009) Development of a therapeutics curriculum to enhance knowledge of fourth-year medical students about clinical uses and
adverse effects of drugs [corrected] [published erratum appears in TEACH LEARN MED 2009 Jul–Sep;21(3):279]. Teaching & Learning in Medicine 21(2):148–
152 5p
76 Sullivan KM, Spooner LM (2008) Adverse-drug-reaction reporting by pharmacy students in a teaching hospital. Am J Health Syst Pharm 65(12):1177–1179
77 Tripathi RK, Jalgaonkar SV, Sarkate PV, Rege NN (2016) Implementation of a module to promote competency in adverse drug reaction reporting in
undergraduate medical students. Indian J Pharmacol 48(Suppl 1):S69–S73
78 Brinkman DJTJ, Schutte T, Benemei S, Böttiger Y, Chamontin B, Christiaens T, Likic R, Maˇiulaitis R, Marandi T, Monteiro EC, Papaioannidou P, Pers
YM, Pontes C, Raskovic A, Regenthal R, Sanz EJ, Tamba BI, Wilson K, Vries T, Richir MC, Agtmael MV (2017) Essential competencies in prescribing: a first
European cross-sectional study among 895 final-year medical students. Clin Pharmacol Ther 101(2):281–289
79 Dekker RS, Schutte T, Tichelaar J, Thijs A, van Agtmael MA, de Vries TP et al (2015) A novel approach to teaching pharmacotherapeutics—feasibility of
the learner-centered student-run clinic. Eur J Clin Pharmacol 71(11):1381–1387
80 Yardley STP, Dornan T (2012) Experiential learning: AMEE Guide No. 63. Med Teach:e102–ee15
81 Urgent need to modernize pharmacovigilance education in healthcare curricula: review of the literature/Michael Reumerman, J. Tichelaar, B. Piersma, M.
C. Richir & M. A. van Agtmael//European Journal of Clinical Pharmacology volume 74, pages1235–1248 (2018)
